Process for the synthesis of compounds for selectin inhibition
    4.
    发明申请
    Process for the synthesis of compounds for selectin inhibition 审中-公开
    用于合成选择素抑制化合物的方法

    公开(公告)号:US20070082923A1

    公开(公告)日:2007-04-12

    申请号:US11543390

    申请日:2006-10-05

    申请人: Youchu Wang

    发明人: Youchu Wang

    IPC分类号: C07D221/06 A61K31/473

    CPC分类号: C07D221/06 C07D221/10

    摘要: The present teachings relate to the field of anti-inflammatory substances, and more particularly to the preparation of compounds that act as antagonists of the mammalian adhesion proteins known as selecting. In some embodiments, the present teachings provide methods for preparing compounds for treating selectin-mediated disorders that have the formula VI: wherein R1, R2, R3, p, and q are defined herein.

    摘要翻译: 本教导涉及抗炎物质的领域,更具体地涉及用作哺乳动物粘附蛋白质的称为选择的拮抗剂的化合物的制备。 在一些实施方案中,本教导提供了制备用于治疗具有式VI的选择素介导的病症的化合物的方法:其中R 1,R 2,R 3 p,q在本文中定义。

    Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof
    6.
    发明申请
    Quinoline Intermediates of Receptor Tyrosine Kinase Inhibitors and the Synthesis Thereof 审中-公开
    喹啉中间体受体酪氨酸激酶抑制剂及其合成

    公开(公告)号:US20090030197A1

    公开(公告)日:2009-01-29

    申请号:US12200120

    申请日:2008-08-28

    IPC分类号: C07D413/02

    CPC分类号: C07D215/54

    摘要: This invention is directed to methods of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): wherein substitutions at LG″, PG, A, G, R1 and R4 are set forth in the specification.

    摘要翻译: 本发明涉及制备4-取代喹啉化合物作为制备受体酪氨酸激酶抑制剂和其方法中使用的中间体化合物的中间体的方法,其中4-取代喹啉化合物具有以下通式(I):其中取代 在LG“,PG,A,G,R1和R4在本说明书中列出。

    Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof
    7.
    发明授权
    Quinoline intermediates of receptor tyrosine kinase inhibitors and the synthesis thereof 失效
    喹啉中间体受体酪氨酸激酶抑制剂及其合成

    公开(公告)号:US07432377B2

    公开(公告)日:2008-10-07

    申请号:US11036408

    申请日:2005-01-14

    IPC分类号: C07D215/38

    CPC分类号: C07D215/54

    摘要: This invention is directed to methods of preparing 4-substituted quinoline compounds as intermediates in the manufacture of receptor tyrosine kinase inhibitors and intermediate compounds used in the methods thereof, wherein the 4-substituted quinoline compound has the following general formula (I): wherein substitutions at LG″, PG, A, G, R1 and R4 are set forth in the specification.

    摘要翻译: 本发明涉及制备4-取代喹啉化合物作为制备受体酪氨酸激酶抑制剂和其方法中使用的中间体化合物的中间体的方法,其中4-取代喹啉化合物具有以下通式(I):其中取代 在LG“,PG,A,G,R 1和R 4”在说明书中列出。